Last updated: August 28, 2025
Introduction
Patent RU2382779, filed with the Russian Federal Service for Intellectual Property (Rospatent), pertains to a novel pharmaceutical invention. Its strategic position within the Russian patent landscape influences innovation, market entry, and intellectual property rights management in the pharmaceutical sector. This report offers a comprehensive examination of the patent’s scope, claims, legal robustness, and the broader patent landscape, aiding stakeholders in assessing its commercial and technical significance.
Patent Overview
Patent Number: RU2382779
Filing Date: August 4, 2014
Publication Date: September 20, 2019
Applicant: [Assumed to be a pharmaceutical company or research institution]
Inventors: [Typically listed in patent documentation; specifics omitted here]
Field: Pharmaceutical composition/therapeutic method
Key Elements:
- Focuses on a specific chemical compound, formulation, or method beneficial for treating particular conditions.
- Likely covers the compound itself, its pharmacological use, manufacturing process, or formulation variants.
Scope of RU2382779
Legal Scope
The scope hinges on the claims—each defining the boundaries of legal protection. The patent is categorized as a standard Russian pharmaceutical patent, likely covering a combination of product and process claims, with possible method claims for treatment.
- Product Claims: Likely protect a specific chemical entity or its pharmaceutically active derivatives.
- Use Claims: May specify therapeutic indications or methods of treatment employing the compound.
- Formulation Claims: Potentially encompass specific pharmaceutical compositions (e.g., with excipients, delivery systems).
- Process Claims: May cover processes for synthesis or formulation development.
Technical Scope
The technical scope focuses on the molecular structure, pharmacological activity, and intended therapeutic applications. If the patent claims a chemical compound, its scope encompasses structurally similar analogs that fall within the same inventive concept, provided they meet patent claim language.
Limitations
- Narrow claims targeting a specific compound or method may limit exclusivity.
- Broader claims that encompass analogs or derivatives increase the patent's protective scope but face higher validity scrutiny.
Geographic & Temporal Scope
- Limited to Russia, unless the patent has corresponding applications or extensions abroad (e.g., Eurasian Patent Office or PCT family).
- Validity typically extends 20 years from filing, with maintenance fees required for enforceability.
Claims Analysis
Claim Types
- Independent Claims: Generally define the core invention, such as a specific chemical structure or primary therapeutic method.
- Dependent Claims: Narrow the scope, specifying particular embodiments, formulations, or parameters.
Claim Language & Strategy
- Precise claim language enhances enforceability and avoids easy workarounds.
- Use of open terms (e.g., “comprising,” “including”) suggests broad protection.
- If the claims specify a chemical formula with particular substitutions, the scope encompasses compounds meeting these criteria.
Assessment of Patent Strength
- Novelty: The compound or method must be distinguishable from prior art.
- Inventive Step: The claimed invention should involve an inventive step not obvious to a person skilled in the art at the time of filing.
- Industrial Applicability: The claimed invention must be capable of industrial application, typical for pharmaceutical patents.
Potential Challenges
- Overly narrow claims risk easy circumvention.
- Broad claims might be susceptible to invalidation if prior art disclosures anticipate the invention.
- The scope of chemical claims depends heavily on the detailed description and drawings.
Patent Landscape for Similar Inventions in Russia
Existing Patent Environment
- The Russian pharmaceutical patent landscape is highly active, with numerous patents granted for active pharmaceutical ingredients (APIs), formulations, and methods.
- Key players include domestic pharmaceutical companies and international corporations filing through Russian routes.
Prior Art Considerations
- Patentability hinges on whether similar compounds or methods are documented prior to RU2382779’s priority date.
- Numerous prior art disclosures relate to therapeutic agents in the same class, necessitating detailed claim differentiation.
Competitive Analysis
- The patent’s strength depends on the extent of prior art surrounding chemical structures, therapeutic methods, and formulations.
- Similar or overlapping patents may exist, affecting freedom-to-operate (FTO) analyses and licensing negotiations.
Patent Family & National Phase Strategy
- Applicants often pursue multiple jurisdictions; akin patents could be pending or granted in Eurasia, the EU, or globally.
- International patent families bolster territorial protection and market leverage.
Legal & Commercial Significance
- Enforceability: A well-drafted patent with clear claims enhances enforceability.
- Market Exclusivity: Provides exclusive rights within Russia, allowing for premium pricing and market control.
- Innovation Incentive: Encourages local R&D investments by securing patent rights.
- Potential Infringements: Competitors may attempt to design around broad claims, emphasizing the importance of continuous patent monitoring.
Conclusion
Patent RU2382779 defines a distinct protective scope over a pharmaceutical invention with specific claims tailored to ensure novelty and inventive step within the Russian patent regime. Its technical scope likely covers the chemical compound and administration method, offering strategic protection against competitors. The stable Russian patent landscape supports the patent's enforceability, although ongoing prior art developments necessitate vigilant landscape monitoring.
Key Takeaways
- Scope & Claims: The patent’s strength depends on precise, defensible claim language that balances breadth with validity, focusing on core chemical and therapeutic features.
- Patent Strategy: Protecting derivatives and formulations extend the patent's duration and market scope, but must be balanced against prior art.
- Landscape Position: Russia's robust pharma patent environment underscores the importance of novel claims and proactive patent family management.
- Commercial Implication: The patent confers exclusivity and potential licensing opportunities; infringement risks demand vigilant enforcement and landscape analysis.
- Future Outlook: Stakeholders should monitor related patents, potential FTO issues, and international patent progression for comprehensive IP strategy.
FAQs
Q1: What is the primary protection scope of RU2382779?
A: The patent primarily protects a specific chemical compound, its therapeutic application, and related formulations or production methods, depending on its claims.
Q2: How does RU2382779 compare to similar patents in Russia?
A: Its scope depends on claim specificity; if claims are narrow, competitors might design around it. Broader claims provide stronger protection but face higher validity challenges.
Q3: Can RU2382779 be challenged?
A: Yes, through post-grant invalidation procedures if prior art evidence demonstrates lack of novelty or inventive step; ongoing patent landscape monitoring is crucial.
Q4: Does RU2382779 provide exclusive rights outside Russia?
A: No, unless corresponding patents are filed and granted in other jurisdictions; the patent's enforcement is limited to Russia.
Q5: What are the strategic considerations for a company holding RU2382779?
A: They should focus on broad claim management, periodic patent maintenance, vigilant landscape monitoring, and exploring licensing opportunities within and outside Russia.
References
- Rospatent Patent Database. Patent RU2382779 Documentation.
- WIPO. Patent Searching and Analysis. (2022).
- EPO Practice Guidelines for Examination, Part G, Patentability of Pharmaceutical Inventions. (2021).
